Navigation path

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece


   Infocentre

Published: 15 March 2016  
Related theme(s) and subtheme(s)
Health & life sciencesCommunicable diseases
International cooperation
Research policySeventh Framework Programme
Countries involved in the project described in the article
France  |  Germany  |  Ireland  |  Israel  |  Netherlands  |  United Kingdom  |  United States
Add to PDF "basket"

The physiology of compulsivity

How much do you know about the effects of glutamate on the frontostriatal circuits? Not as much as you'd like, possibly, but then again there is still a lot to learn. EU-funded researchers are studying the role of this neurotransmitter and potential genetic factors in the development of compulsive disorders such as autism, ADHD and OCD.

Picture of small boy obscuring the ears

© ladybirdstudio - fotolia.com

The Tactics programme strives to identify the genetic and neural underpinnings of compulsivity in children and adolescents, and explore new possibilities for treatment,” says project coordinator Jan Buitelaar of Radboud University Medical Centre in Nijmegen, Netherlands. The research focuses on three types of illness: autism spectrum disorders, obsessive-compulsive disorders (OCDs), and conditions linked to impulse control, which notably include attention-deficit hyperactive disorder (ADHD).

More specifically, Tactics is investigating suspected links with the brain’s production and processing of glutamate and analysing possible genetic risk factors. It is also establishing whether a glutamate-modulating drug currently used to treat Alzheimer’s disease could be of help.

Halfway into the four-year project, the partners have already reported exciting results. Their findings indicate that young patients’ inability to pursue long-term rewards may be linked with an overactive glutamate system, Buitelaar explains. However, he says, this mechanism is not apparent in adults struggling with impulse control, whose brain scans actually tend to reveal lower glutamate signals.

In addition, the team has spotted a potential connection between compulsivity and insulin. Central to glucose control and the body’s energy metabolism, this hormone also appears to contribute to the functioning of the brain.

Beyond predisposition

Compulsive disorders can be brought on by a number of causes. Genetic predisposition is one of them, says Buitelaar, but this is unlikely to originate in a single gene. It is more a case of “genetic landscapes” conducive to compulsivity, he explains, i.e. hundreds of genes presenting specificities that jointly increase the risk.

There are many different types of compulsive disorder, characterised by symptoms as diverse as relentless cleaning, a persistent inability to sit still, or uncontrollable gambling. The myriad of genes involved may jointly shape physiological processes that could be targeted with drugs, Buitelaar explains.

The partners are also generating new knowledge about the neural wiring linked to compulsivity. Their attention focuses particularly on the frontostriatal cortex, the connection between the frontal lobes of the brain and the so-called basal ganglia, which are notably involved in repetitive and reward-related behaviours.

Compelling (bio)chemistry

“We think that the frontostriatal circuits are not functioning well in children with clinical symptoms of compulsivity,” says Buitelaar. “We are investigating the effects of glutamate, one of the more powerful neurotransmitter systems modulating the activity of these circuits.”

“In particular,” he adds, “we are exploring whether interventions in the glutamate system can influence their function.” Research on mice and rats has led Tactics to conclude that this approach does indeed show promise if the compulsivity problem expresses itself in a reward-related disorder.

This finding was not unexpected, Buitelaar notes, but the realisation that insulin may also play a role in compulsivity came as a surprise. In fact, he adds, this role may be even greater than that of glutamate.

A need to succeed

“We focus on children between 8 and 12 because there are a lot of changes in brain function and structure at that age,” Buitelaar explains. “This stage is also the beginning of puberty, where risk increases for reward-related substance abuse or addictive behaviours.”

Breakthroughs in identifying kids that might be prone to compulsive disorders such as these could thus help to keep them healthy as they grow up. It would also greatly reduce the prospective burden on their families and on society. Compulsivity can come at a great cost to the patient and to the wider world — for example in cases where the disorder limits a person’s ability to refrain from harmful behaviour.

There is still a long way to go, but promising leads have begun to emerge. “Research brings us closer to the real mechanisms, and so closer to potential treatments,” Buitelaar concludes.

Project details

  • Project acronym: TACTICS
  • Participants: Netherlands (Coordinator), Germany, UK, Israel, Ireland, United States, France
  • FP7 Proj. N° 278948
  • Total costs: € 7 871 883
  • EU contribution: € 6 000 000
  • Duration: January 2012 - December 2016

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project website
Project information on CORDIS






  Top   Research Information Center
 
Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece